B Froeliger1, P A McConnell2, N Stankeviciute2, E A McClure3, P W Kalivas2, K M Gray3. 1. Department of Neuroscience, Medical University of South Carolina, United States; Hollings Cancer Center, Medical University of South Carolina, United States; Department of Psychiatry, Medical University of South Carolina, United States. Electronic address: froelige@musc.edu. 2. Department of Neuroscience, Medical University of South Carolina, United States. 3. Department of Psychiatry, Medical University of South Carolina, United States.
Abstract
BACKGROUND: Chronic exposure to drugs of abuse disrupts frontostriatal glutamate transmission, which in turn meditates drug seeking. In animal models, N-Acetylcysteine normalizes dysregulated frontostriatal glutamatergic neurotransmission and prevents reinstated drug seeking; however, the effects of N-Acetylcysteine on human frontostriatal circuitry function and maintaining smoking abstinence is unknown. Thus, the current study tested the hypothesis that N-Acetylcysteine would be associated with stronger frontostriatal resting-state functional connectivity (rsFC), attenuated nicotine withdrawal and would help smokers to maintain abstinence over the study period. METHODS: The present study examined the effects of N-Acetylcysteine on frontostriatal rsFC, nicotine-withdrawal symptoms and maintaining abstinence. Healthy adult, non-treatment seeking smokers (N=16; mean (SD) age 36.5±11.9; cigs/day 15.8±6.1; years/smoking 15.7±8.9) were randomized to a double-blind course of 2400mg N-Acetylcysteine (1200mg b.i.d.) or placebo over the course of 3½ days of monetary-incentivized smoking abstinence. On each abstinent day, measures of mood and craving were collected and participants attended a lab visit in order to assess smoking (i.e., expired-air carbon monoxide [CO]). On day 4, participants underwent fMRI scanning. RESULTS: As compared to placebo (n=8), smokers in the N-Acetylcysteine group (n=8) maintained abstinence, reported less craving and higher positive affect (all p's<.01), and concomitantly exhibited stronger rsFC between ventral striatal nodes, medial prefrontal cortex and precuneus-key default mode network nodes, and the cerebellum [p<.025; FWE]). CONCLUSIONS: Taken together, these findings suggest that N-Acetylcysteine may positively affect dysregulated corticostriatal connectivity, help to restructure reward processing, and help to maintain abstinence immediately following a quit attempt.
RCT Entities:
BACKGROUND: Chronic exposure to drugs of abuse disrupts frontostriatalglutamate transmission, which in turn meditates drug seeking. In animal models, N-Acetylcysteine normalizes dysregulated frontostriatal glutamatergic neurotransmission and prevents reinstated drug seeking; however, the effects of N-Acetylcysteine on human frontostriatal circuitry function and maintaining smoking abstinence is unknown. Thus, the current study tested the hypothesis that N-Acetylcysteine would be associated with stronger frontostriatal resting-state functional connectivity (rsFC), attenuated nicotine withdrawal and would help smokers to maintain abstinence over the study period. METHODS: The present study examined the effects of N-Acetylcysteine on frontostriatal rsFC, nicotine-withdrawal symptoms and maintaining abstinence. Healthy adult, non-treatment seeking smokers (N=16; mean (SD) age 36.5±11.9; cigs/day 15.8±6.1; years/smoking 15.7±8.9) were randomized to a double-blind course of 2400mg N-Acetylcysteine (1200mg b.i.d.) or placebo over the course of 3½ days of monetary-incentivized smoking abstinence. On each abstinent day, measures of mood and craving were collected and participants attended a lab visit in order to assess smoking (i.e., expired-air carbon monoxide [CO]). On day 4, participants underwent fMRI scanning. RESULTS: As compared to placebo (n=8), smokers in the N-Acetylcysteine group (n=8) maintained abstinence, reported less craving and higher positive affect (all p's<.01), and concomitantly exhibited stronger rsFC between ventral striatal nodes, medial prefrontal cortex and precuneus-key default mode network nodes, and the cerebellum [p<.025; FWE]). CONCLUSIONS: Taken together, these findings suggest that N-Acetylcysteine may positively affect dysregulated corticostriatal connectivity, help to restructure reward processing, and help to maintain abstinence immediately following a quit attempt.
Authors: Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves Journal: JAMA Date: 2006-07-05 Impact factor: 56.272
Authors: Brett Froeliger; Leslie A Modlin; Rachel V Kozink; Lihong Wang; Eric L Garland; Merideth A Addicott; F Joseph McClernon Journal: Psychiatry Res Date: 2012-11-13 Impact factor: 3.222
Authors: Erin A McClure; Nathaniel L Baker; Susan C Sonne; Udi E Ghitza; Rachel L Tomko; LaTrice Montgomery; Shanna Babalonis; Garth E Terry; Kevin M Gray Journal: Drug Alcohol Depend Date: 2018-08-25 Impact factor: 4.492
Authors: Patrick A McConnell; Eric L Garland; Jon-Kar Zubieta; Roger Newman-Norlund; Shannon Powers; Brett Froeliger Journal: Addict Biol Date: 2019-04-04 Impact factor: 4.280
Authors: Claire E Wilcox; Joshua Clifford; Josef Ling; Andrew R Mayer; Rose Bigelow; Michael P Bogenschutz; J Scott Tonigan Journal: Brain Imaging Behav Date: 2020-04 Impact factor: 3.978
Authors: Brett Froeliger; Patrick A McConnell; Spencer Bell; Maggie Sweitzer; Rachel V Kozink; Christie Eichberg; Matt Hallyburton; Nicole Kaiser; Kevin M Gray; F Joseph McClernon Journal: JAMA Psychiatry Date: 2017-04-01 Impact factor: 21.596
Authors: Claire E Wilcox; Vince D Calhoun; Srinivas Rachakonda; Eric D Claus; Rae A Littlewood; Jessica Mickey; Pamela B Arenella; Kent E Hutchison Journal: Psychiatry Res Neuroimaging Date: 2017-04-30 Impact factor: 2.376
Authors: Lindsay M Squeglia; Nathaniel L Baker; Erin A McClure; Rachel L Tomko; Vitria Adisetiyo; Kevin M Gray Journal: Addict Behav Date: 2016-08-04 Impact factor: 3.913